Activation of extracellular signal-regulated kinase in human prostate cancer.
暂无分享,去创建一个
L. Luttrell | D. Price | D. Schwinn | G. D. Della Rocca | G. D. Rocca | M. Ballo | C. Guo
[1] H. Frierson,et al. Activation of mitogen-activated protein kinase associated with prostate cancer progression. , 1999, Cancer research.
[2] R. Lefkowitz,et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. , 1998, Science.
[3] K. Meier,et al. Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC‐3 human prostate cancer cells , 1998, Journal of cellular physiology.
[4] J. Neary. MAPK CASCADES IN CELL GROWTH AND DEATH , 1997 .
[5] G. Nuovo,et al. Hyperexpression of mitogen-activated protein kinase in human breast cancer. , 1997, The Journal of clinical investigation.
[6] M. Cobb,et al. Mitogen-activated protein kinase pathways. , 1997, Current opinion in cell biology.
[7] W. Rayford,et al. Muscarinic cholinergic receptors promote growth of human prostate cancer cells , 1997, The Prostate.
[8] I. Leav,et al. Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate. , 1996, Carcinogenesis.
[9] M. Loda,et al. Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[10] S. Magnuson,et al. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. , 1996, Cancer research.
[11] M. Kawaichi,et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. , 1995, Cancer research.
[12] M. Steiner,et al. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. , 1995, The Journal of urology.
[13] A. Brunet,et al. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. , 1994, Oncogene.
[14] C. Logothetis,et al. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. , 1993, The Journal of urology.
[15] D. Peehl. Oncogenes in prostate cancer. An update , 1993, Cancer.
[16] M. Ciomei,et al. Bombesin stimulates growth of human prostatic cancer cells in vitro , 1990, Cancer.
[17] M. Loda,et al. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[18] A. Brunet,et al. [MAP kinase module: role in the control of cell proliferation]. , 1995, Comptes rendus des seances de la Societe de biologie et de ses filiales.
[19] I. Leav,et al. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats. , 1993, Laboratory investigation; a journal of technical methods and pathology.